Business services providers thrive by solving complex operational challenges for their clients, allowing them to focus on ...

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of ...

Equifax® (NYSE: EFX) today announced that the Equifax Board of Directors declared a quarterly dividend of $0.50 per share, payable on September 15, 2025, to shareholders of record as of the close of ...

Equifax faces growth headwinds, premium valuation, and flat price action despite AI and cloud investments, with limited ...

Equifax Inc. Annual stock financials by MarketWatch. View the latest EFX financial statements, income statements and financial ratios.

Let's take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with ...

The case involved a clinical trial of Akero's only product, a drug candidate aimed at treating a liver disease. It's the ...

EFX is now being further evaluated in three ongoing Phase 3 trials targeting all stages of MASH. EFX, Akero's lead candidate, is an FGF21 analog designed for once-weekly dosing.

The EFX-A1 from M.A.G.S LLC is a drop in replacement for the M16 (M16A2/M16A3/ M16A4), and gives an A1 stock length with an improved cheekweld. EFX-A1 translates to Enhanced Fixed Stock, with the ...